Recent News Stories, Press Releases, and Company Announcements
COVID-19 Rapid Test Kits Global Market Report 2021
Hememics Biotechnologies Inc. partnered with Biomedical Research and Development Authority (BARDA) to develop a rapid antibody and antigen diagnostic tool.
Graphene Biosensor Evolution: The Practical Applications of Graphene
Graphene's unique properties provide some very practical applications in biosensors.
Hememics Biotechnologies Inc. Receives $400k Investment From Dai Viet Inc.
Dai Viet invests $400k into Hememics.
Not All COVID-19 Tests Are Created Equal - New Biosensors to Improve Speed and Connectivity
As the COVID-19 pandemic rages on, Hememics Biotechnologies's Biosensors are redefining rapid tests.
Dai Viet Signs for Investment Cooperation with Hememics Biotechnologies Inc. USA
Dai Viet group invests in Hememics.
NOVA Investors Band Together and Invest in Hememics
Local businesses and entities in NOVA have banded together to invest in Hememics.
Biosensors May Hold the Key to Mass Coronavirus Testing
Dry proteins are Hememics "Special Sauce" in antigen detection.
New Coronavirus Test Could Diagnose the Virus in 60 Seconds or Less
The potential for the Hememics biosensor to detect COVID in under a minute has the potential to address a critical issue in identifying those with active infections vs those with antibodies.
Inova Personalized Health Accelerator Accepts Hememics Biotechnologies, Inc. Into Portfolio
Hememics enters Inova investment portfolio.